EptaplatinAlternative Names: Heptaplatin; NSC 644591; NSC D 644591; SKI 2053R; Sunpla
Latest Information Update: 18 Sep 2001
At a glance
- Originator SK Pharma
- Class Antineoplastics; Platinum complexes; Small molecules
- Mechanism of Action DNA inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Cancer